Any questions? Contact us+49 761-389 49-0

LeukoStrat® CDx FLT3 Mutation Assay, ABI

LeukoStrat® CDx FLT3 Mutation Assay, ABI CE

LeukoStrat® CDx FLT3 Mutation Assay, ABI

#K-412-0291

The LeukoStrat® CDx FLT3 Mutation Assay is a PCR-based in vitro diagnostic test designed to detect internal tandem duplications (ITD) and tyrosine kinase domain (TKD) mutations D835 and I836 in the FLT3 gene.

€1,895.00 *

Prices plus VAT plus shipping costs

Delivery time 7 Workdays

Size: 33 rxns
  • K-412-0291
The LeukoStrat® FLT3 Mutation Assay 2.0 is an in vitro diagnostic product intended for PCR-based... more

The LeukoStrat® FLT3 Mutation Assay 2.0 is an in vitro diagnostic product intended for PCR-based detection of FLT3 activating mutations in patients with acute myelogenous leukemia (AML). Specifically, the FLT3 Mutation Assay 2.0 can be used to: Identify internal tandem duplications (ITD) in the FLT3 gene Identify tyrosine kinase domain (TKD) mutations in the FLT3 gene.


For additional information about the product, please visit the manufacturer's website.
PROPERTIES
storage temperature: -70 °C
shipping method: dry ice
regulatory status: CE-IVD
detection platform: ABI
Viewed